Legal Name: ORBIMED ADVISORS LLC
報告期間:
Jun 30, 2019
有効日:
Aug 14, 2019
| セキュリティ |
保有株式/元本 |
市場価格 |
オプション |
|
ASCENDIS PHARMA A S (04351P101)
|
3,846,673 |
$442,944k |
|
|
TRICIDA INC (89610F101)
|
11,114,280 |
$438,569k |
|
|
BOSTON SCIENTIFIC (101137107)
|
6,752,500 |
$290,222k |
|
|
ALEXION PHARMACEUTICALS INC CO (015351109)
|
1,926,085 |
$252,279k |
|
|
ALECTOR INC (014442107)
|
13,182,329 |
$250,464k |
|
|
MERCK & CO INC (58933Y105)
|
2,570,100 |
$215,503k |
|
|
PREVAIL THERAPEUTICS INC COM (74140Y101)
|
13,822,463 |
$182,457k |
|
|
Vertex Pharmaceuticals Inc (92532F100)
|
973,300 |
$178,484k |
|
|
Neurocrine Biosciences Inc. (64125C109)
|
1,833,200 |
$154,777k |
|
|
Iovance Biotherapeutics Inc (462260100)
|
5,548,326 |
$136,045k |
|
|
Thermo Fisher Scientific Inc (883556102)
|
462,800 |
$135,915k |
|
|
EDWARDS LIFESCIENCE (28176E108)
|
715,000 |
$132,089k |
|
|
Sarepta Therapeutics Inc (803607100)
|
828,400 |
$125,875k |
|
|
WRIGHT MEDICAL GROUP NV (NE) (N96617118)
|
4,187,799 |
$124,880k |
|
|
INTUITIVE SURGIC INC (46120E602)
|
210,300 |
$110,313k |
|
|
TURNING POINT THERAPEUTICS I (90041T108)
|
2,567,550 |
$104,499k |
|
|
ANTHEM INC (036752103)
|
361,600 |
$102,047k |
|
|
BAUSCH HEALTH COMPAN (071734107)
|
3,740,700 |
$94,340k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
2,089,700 |
$94,037k |
|
|
INSPIRE MED SYS INC COM (457730109)
|
1,471,000 |
$89,216k |
|
|
NATERA INC (632307104)
|
3,224,328 |
$88,927k |
|
|
LOGICBIO THERAPEUTICS INC (54142F102)
|
6,466,783 |
$84,068k |
|
|
EXELIXIS INC (30161Q104)
|
3,912,900 |
$83,619k |
|
|
AVEDRO INC COM (05355N109)
|
4,240,128 |
$83,276k |
|
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
3,618,171 |
$81,590k |
|
|
ABBOTT LABS (002824100)
|
938,000 |
$78,886k |
|
|
EHEALTH INC COM (28238P109)
|
909,814 |
$78,335k |
|
|
ATHENEX INC (04685N103)
|
3,840,130 |
$76,035k |
|
|
SYNTHORX INC (87167A103)
|
5,316,355 |
$71,824k |
|
|
UNIQURE N.V. (N90064101)
|
897,800 |
$70,163k |
|
|
MEIRAGTX HOLDINGS PLC (G59665102)
|
2,586,951 |
$69,537k |
|
|
Regeneron Pharmaceuticals Inc (75886F107)
|
215,800 |
$67,545k |
|
|
AGILENT TECHNOLOGIES INC (00846U101)
|
893,200 |
$66,695k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
1,713,069 |
$64,857k |
|
|
ARVINAS INC (04335A105)
|
2,678,810 |
$58,907k |
|
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
1,605,713 |
$53,294k |
|
|
Illumina Inc (452327109)
|
140,200 |
$51,615k |
|
|
CRINETICS PHARMACE (22663K107)
|
2,039,282 |
$50,982k |
|
|
RESTORBIO INC (76133L103)
|
4,830,387 |
$49,270k |
|
|
MYOKARDIA INC (62857M105)
|
955,300 |
$47,899k |
|
|
VIEWRAY INC COM (92672L107)
|
5,149,019 |
$45,363k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
310,400 |
$43,946k |
|
|
ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (98887Q104)
|
1,169,000 |
$40,763k |
|
|
NEXTCURE INC (65343E108)
|
2,711,013 |
$40,611k |
|
|
CIGNA CORP (125523100)
|
252,600 |
$39,797k |
|
|
DEXCOM INC (252131107)
|
262,900 |
$39,393k |
|
|
TANDEM DIABETES CARE (875372203)
|
570,790 |
$36,827k |
|
|
PROTHENA CORP PLC (G72800108)
|
3,065,278 |
$32,400k |
|
|
HARPOON THERAPEUTICS INC (41358P106)
|
2,446,409 |
$31,803k |
|
|
CAREDX INC COM (14167L103)
|
827,600 |
$29,785k |
|
|
OBSEVA SA (H5861P103)
|
2,605,531 |
$29,469k |
|
|
SPDR S&P 500 ETF TR TR UNIT (78462F103)
|
100,000 |
$29,300k |
Put |
|
CLOVIS ONCOLOGY INC COM (189464100)
|
1,913,234 |
$28,450k |
|
|
XTANT MED HLDGS INC (98420P308)
|
9,207,012 |
$27,621k |
|
|
MYLAN N V (n59465109)
|
1,373,305 |
$26,148k |
|
|
KRYSTAL BIOTECH INC (501147102)
|
642,006 |
$25,854k |
|
|
ENDO INTL PLC (G30401106)
|
6,165,464 |
$25,402k |
|
|
CORVUS PHARMACEUTICALS INC (221015100)
|
6,565,685 |
$24,556k |
|
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
1,960,200 |
$23,307k |
|
|
AURINIA PHARMACEUTICALS INC (05156V102)
|
3,531,002 |
$23,234k |
|
|
Bristol-Myers Squibb Co (110122108)
|
500,000 |
$22,675k |
Call |
|
SPARK THERAPEUTICS INC (84652J103)
|
219,900 |
$22,513k |
|
|
AMGEN INC (031162100)
|
122,100 |
$22,501k |
|
|
GENFIT SA ADR (372279109)
|
1,125,607 |
$22,231k |
|
|
Kala Pharmaceuticals, Inc. (483119103)
|
3,447,840 |
$21,997k |
|
|
ALCON INC (H01301128)
|
351,380 |
$21,682k |
|
|
BIOGEN INC (09062X103)
|
87,700 |
$20,510k |
|
|
SI BONE INC COM (825704109)
|
985,368 |
$20,042k |
|
|
KARYOPHARM THERAPEUTICS INC (48576U106)
|
3,148,475 |
$18,859k |
|
|
SYNLOGIC INC (87166L100)
|
2,029,996 |
$18,473k |
|
|
TAKEDA PHARMACEUTICAL CO LTD (874060205)
|
1,000,000 |
$17,700k |
Call |
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
787,300 |
$17,321k |
|
|
VERRICA PHARMACEUTICALS INC (92511W108)
|
1,479,733 |
$17,194k |
|
|
NOVO-NORDISK AS (670100205)
|
330,000 |
$16,843k |
|
|
SINOVAC BIOTECH LTD (P8696W104)
|
2,839,500 |
$16,611k |
|
|
Alpine Immune Sciences Inc (02083G100)
|
3,670,955 |
$15,455k |
|
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
2,165,524 |
$14,834k |
|
|
ABBVIE INC (00287Y109)
|
200,000 |
$14,544k |
Call |
|
X4 PHARMACEUTICALS INC (98420X103)
|
936,493 |
$14,047k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
717,600 |
$13,914k |
|
|
PROQR THRAPEUTICS N V (N71542109)
|
1,382,502 |
$12,581k |
|
|
FOAMIX PHARMACUTICLS (M46135105)
|
5,195,330 |
$12,365k |
|
|
IMMUNOMEDICS INC (452907108)
|
818,200 |
$11,348k |
|
|
NABRIVA THERAPEUTICS PLC SHS (G63637105)
|
4,644,600 |
$11,286k |
|
|
STRYKER CORP (863667101)
|
54,000 |
$11,101k |
|
|
ARQULE INC (04269E107)
|
1,000,000 |
$11,010k |
|
|
SCPHARMACEUTICALS INC (810648105)
|
3,409,865 |
$10,877k |
|
|
PFIZER INC (717081103)
|
250,000 |
$10,830k |
Put |
|
CONSTELLATION PHARMCETICLS I (210373106)
|
835,842 |
$10,264k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
100,000 |
$9,435k |
Put |
|
PERSONALIS INC (71535D106)
|
300,000 |
$8,145k |
|
|
PUMA BIOTECHNOLOGY INC (74587V107)
|
624,249 |
$7,934k |
|
|
MERSANA THERAPEUTICS INC (59045L106)
|
1,891,119 |
$7,659k |
|
|
Assembly Biosciences Inc (045396108)
|
523,600 |
$7,063k |
|
|
GILEAD SCIENCES INC (375558103)
|
100,000 |
$6,756k |
Call |
|
AMICUS THERAPEUTICS INC (03152W109)
|
518,309 |
$6,468k |
|
|
ARENA PHARMACEUTICALS INC COM NEW (040047607)
|
110,000 |
$6,449k |
|
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
75,000 |
$6,424k |
Put |
|
VERONA PHARMA PLC (925050106)
|
1,250,396 |
$6,377k |
|
|
XENON PHARMACEUTICALS INC (98420N105)
|
634,812 |
$6,259k |
|
|
SPERO THERAPEUTICS INC (84833T103)
|
507,471 |
$5,841k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
120,000 |
$5,796k |
|
|
MEDICINES CO (584688105)
|
151,515 |
$5,526k |
|
|
ADAPTIMMUNE THERAPEUTICS PLC (00653A107)
|
1,350,655 |
$5,430k |
|
|
Intellia Therapeutics Inc (45826J105)
|
327,600 |
$5,363k |
|
|
SELECTA BIOSCIENCES INC (816212104)
|
2,879,064 |
$5,154k |
|
|
Ultragenyx Pharmaceutical Inc (90400D108)
|
79,607 |
$5,055k |
|
|
AERPIO PHARMACEUTICALS INC (00810B105)
|
5,193,946 |
$4,726k |
|
|
CTI BIOPHARMA CORP (12648L601)
|
5,000,000 |
$4,297k |
|
|
MENLO THERAPEUTICS (586858102)
|
673,700 |
$4,035k |
|
|
STOKE THERAPEUTICS INC COM (86150R107)
|
130,000 |
$3,792k |
|
|
NOVUS THERAPEUTICS INC (67011N105)
|
3,183,314 |
$3,215k |
|
|
REALM THERAPEUTICS PLC (75606L103)
|
1,021,484 |
$2,870k |
|
|
ACADIA PHARMACEUTCLS (004225108)
|
101,900 |
$2,724k |
|
|
DYNAVAX TECHNOLOGIES CORP (268158201)
|
583,500 |
$2,328k |
|
|
SYNDAX PHARMACEUTICALS INC (87164F105)
|
212,000 |
$1,974k |
|
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
75,000 |
$1,901k |
Call |
|
AVROBIO INC (05455M100)
|
106,000 |
$1,724k |
|
|
MARINUS PHARMACEUTICALS INC CO (56854Q101)
|
398,101 |
$1,652k |
|
|
NUVECTRA CORP (67075N108)
|
350,000 |
$1,173k |
|
|
FLEXION THERAPEUTICS INC COM (33938J106)
|
89,919 |
$1,106k |
|
|
BIOLINERX LTD (09071M106)
|
1,038,600 |
$379k |
|
|
MEDIGUS LTD (58471G300)
|
15,000 |
$37k |
|
